3 completed, 1 terminated. 3 Phase 3, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Terminated 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Tricida, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Effect of TRC101 on Progression of Chronic Kidney Disease in Subjects With Metabolic Acidosis TRC101, Placebo - Metabolic Acidosis, Chronic Kidney Disease | Phase 3 | Terminated | Tricida, Inc. | 1480 | 2018-11-20 | 2022-10-14 |
| Long-term Safety Extension to Study TRCA-301 TRC101, Placebo - Metabolic Acidosis | Phase 3 | Completed | Tricida, Inc. | 196 | 2017-12-20 | 2021-10-22 |
| Evaluation of TRC101 in Subjects With Metabolic Acidosis Associated With Chronic Kidney Disease TRC101, Placebo - Metabolic Acidosis | Phase 3 | Completed | Tricida, Inc. | 217 | 2017-09-26 | 2021-04-26 |
| Evaluation of TRC101 in Subjects With Chronic Kidney Disease and Metabolic Acidosis Placebo, TRC101 - Acidosis | Phase 1 / Phase 2 | Completed | Tricida, Inc. | 135 | 2016-03-01 | 2020-01-14 |
Acidosis (4) · Kidney Diseases (3) · Renal Insufficiency, Chronic (1)
veverimer (4)
Bulgaria (4) · Georgia (4) · Hungary (3) · Serbia (3) · Ukraine (3) · United States (3) · Slovenia (2) · Albania (1) · Argentina (1) · Armenia (1) · Australia (1) · Belarus (1) · Belgium (1) · Brazil (1) · Canada (1)
Yuri Stasiv, PhD (1)
PMID 29102959, PMID 30857647, PMID 31248662, PMID 34009141, PMID 35216581, PMID 38261535
2015 (1), 2016 (1), 2018 (1)